Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group
Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group
复制标题
DOI：
10.1007/s00259-019-04340-5
复制
发表时间：
2019-07-01
影响因子：
9.1
通讯作者：
Garin, Etienne
中科院分区：
文献类型：
--
作者：
Salem, Riad;Padia, Siddharth A.;Garin, Etienne
TheraSphere全球剂量学指导委员会由BTG International于2017年成立，旨在审查现有数据并解决剂量学相关知识的差距。该委员会由在辐射剂量测定方面具有不同专业领域和观点的卫生保健提供者组成。这些建议的目的是优化玻璃微球放射治疗肝细胞癌，同时考虑到包括疾病表现，肿瘤血管分布，肝功能和治愈/姑息意图在内的变量。这些建议旨在统一玻璃微球用户的标准化剂量测定方法，该方法简单，可重复，并得到临床数据的支持，其总体目标是改善临床结局并提高剂量测定知识。
The TheraSphere Global Dosimetry Steering Committee was formed in 2017 by BTG International to review existing data and address gaps in knowledge related to dosimetry. This committee is comprised of health care providers with diverse areas of expertise and perspectives on radiation dosimetry. The goal of these recommendations is to optimize glass microspheres radiation therapy for hepatocellular carcinoma while accounting for variables including disease presentation, tumour vascularity, liver function, and curative/palliative intent. The recommendations aim to unify glass microsphere users behind standardized dosimetry methodology that is simple, reproducible and supported by clinical data, with the overarching goal of improving clinical outcomes and advancing the knowledge of dosimetry.